Evidence map›Paper›PMID 39282509›Full record

ReviewF1000Research2023

Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer.

Bridget M Fortin, Alisa L Mahieu, Rachel C Fellows, Nicholas R Pannunzio, Selma Masri

Abstract readReview
In one paragraph

Review in F1000Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Circadian clock and cancer.Military Medical Research · 2026
    Review
  6. Article
  7. Impact of Circadian ClockInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bridget M FortinDepartment of Biological Chemistry, University of California, Irvine, Irvine, California, 92697, USA.ORCID 0000-0001-9080-6443
Alisa L MahieuDepartment of Biological Chemistry, University of California, Irvine, Irvine, California, 92697, USA.ORCID 0000-0003-1744-2211
Rachel C FellowsDepartment of Biological Chemistry, University of California, Irvine, Irvine, California, 92697, USA.
Nicholas R PannunzioDepartment of Biological Chemistry, University of California, Irvine, Irvine, California, 92697, USA.ORCID 0000-0002-8290-8236
Selma MasriDepartment of Biological Chemistry, University of California, Irvine, Irvine, California, 92697, USA.ORCID 0000-0002-8619-8331

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
CARCINOGENESIST32CA009054 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDINGER, AIMEE L, FRUMAN, DAVID ALEXANDER · 1985 to 2025
$8.6M
Circadian Clock and Myc-dependent Regulation of Cellular TransformationR01CA259370 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Selma Masri · 2022 to 2026
$3.0M
Circadian Clock Disruption and Colorectal CancerR01CA244519 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Selma Masri · 2020 to 2026
$3.0M
Rapid detection of CRLF2 rearrangements in Hispanic Ph-like ALL patients to access diagnosis and relapseR37CA266042 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Nicholas Pannunzio · 2022 to 2026
$2.5M
NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA244519NCI NIH HHS R01 CA259370NCI NIH HHS R37 CA266042NCI NIH HHS T32 CA009054
6 · The paper itself

Abstract

In modern society, there is a growing population affected by circadian clock disruption through night shift work, artificial light-at-night exposure, and erratic eating patterns. Concurrently, the rate of cancer incidence in individuals under the age of 50 is increasing at an alarming rate, and though the precise risk factors remain undefined, the potential links between circadian clock deregulation and young-onset cancers is compelling. To explore the complex biological functions of the clock, this review will first provide a framework for the mammalian circadian clock in regulating critical cellular processes including cell cycle control, DNA damage response, DNA repair, and immunity under conditions of physiological homeostasis. Additionally, this review will deconvolute the role of the circadian clock in cancer, citing divergent evidence suggesting tissue-specific roles of the biological pacemaker in cancer types such as breast, lung, colorectal, and hepatocellular carcinoma. Recent evidence has emerged regarding the role of the clock in the intestinal epithelium, as well as new insights into how genetic and environmental disruption of the clock is linked with colorectal cancer, and the molecular underpinnings of these findings will be discussed. To place these findings within a context and framework that can be applied towards human health, a focus on how the circadian clock can be leveraged for cancer prevention and chronomedicine-based therapies will be outlined.

Indexed as

Circadian ClocksNeoplasmsAnimalsCircadian RhythmHumanscancerchronomedicinechronotherapycircadian clockcolorectal cancerearly-onset cancernight shift workWnt signaling

Identifiers

PMID39282509
PMCPMC11399774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.